연구성과로 돌아가기

2023 연구자 정보 (142 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kong, Doo-Sik
(Kong, DS) ⓘ 		Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma ⓘ SCIE ⓘ 4.5 GENETICS & HEREDITY ⓘ nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; ⓘ
Koo, Harim
(Koo, H) ⓘ 		Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea
Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea
Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang, South Korea
Natl Canc Ctr, Res Inst & Hosp, Dept Clin Res, Goyang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma ⓘ SCIE ⓘ 4.5 GENETICS & HEREDITY ⓘ nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; ⓘ
Koo, KwangJoo (KJ)
(Koo, K) ⓘ 		교신저자 Kyungpook Natl Univ, Coll Econ & Business Adm, Daegu, South Korea
Kyungpook Natl Univ, 80,Daehak Ro, Daegu, South Korea ⓘ 		AAM-6949-2020
Koo, KwangJoo ⓘ
ⓘ 		[JCR상위 4.5] The dark side of tournaments: Evidence from innovation performance ⓘ SSCI ⓘ 4.5 BUSINESS, FINANCE ⓘ kjkoo@knu.ac.kr; ⓘ
Kuk, Jang Byoung
(Kuk, JB) ⓘ 		Keimyung Univ, Sch Med, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆ ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kurosaki, Masayuki
(Kurosaki, M) ⓘ 		Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
Musashino Red Cross Hosp, Tokyo, Japan ⓘ
ⓘ 		0000-0001-7016-8931
Kurosaki, Masayuki ⓘ 		[JCR상위 4.5] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY
[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report ⓘ 		SCIE ⓘ 1.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net;
robert.c.elston@gsk.com; ⓘ
Kweon, Young-Oh
(Kweon, YO) ⓘ 		Kyungpook Natl Univ, Daegu, South Korea
Kyungpook Natl Univ, Coll Med, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆
[JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY
[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR ⓘ 		SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kwon, Yong-Jun
(Kwon, YJ) ⓘ 		Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea ⓘ
ⓘ 		0000-0002-7249-3014
Kwon, Yong-Jun ⓘ 		[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma ⓘ SCIE ⓘ 4.5 GENETICS & HEREDITY ⓘ nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; ⓘ
Lee, Chang-Hyeong
(Lee, CH) ⓘ 		Daegu Catholic Univ, Sch Med, Gyongsan, South Korea
Daegu Catholic Univ, Sch Med, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆
[JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY ⓘ 		SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Lee, Hyung Woong
(Lee, HW) ⓘ 		Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net; ⓘ
Lee, Jeong-Hoon
(Lee, JH) ⓘ 		Seoul Natl Univ, Coll Med, Seoul, South Korea
Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea ⓘ 		AAM-3893-2021
Q-1055-2018
Lee, Dong-Hyeon
Lee, Jeong-Hoon ⓘ 		0000-0002-0315-2080
Lee, Jeong-Hoon ⓘ 		[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY
[JCR상위 1.7] A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
[JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study ⓘ 		SCIE ⓘ 1.7 GASTROENTEROLOGY & HEPATOLOGY ⓘ mfyuen@hku.hk;
mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; ⓘ
Lee, Jin
(Lee, J) ⓘ 		Univ Calif San Diego, La Jolla, CA USA
Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS
[JCR상위 17.8] A Report on a Nationwide Surveillance System for Pediatric Acute Hepatitis of Unknown Etiology in Korea ⓘ 		SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, GENERAL & INTERNAL ⓘ 		moonmissing@gmail.com; ⓘ
Lee, Jin-Woo
(Lee, JW) ⓘ 		Inha Univ, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Lee, Jung-Il
(Lee, JI) ⓘ 		Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma ⓘ SCIE ⓘ 4.5 GENETICS & HEREDITY ⓘ nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; ⓘ
Lee, Kyoungmin
(Lee, K) ⓘ 		Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma ⓘ SCIE ⓘ 4.5 GENETICS & HEREDITY ⓘ nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; ⓘ
Lee, SangKyu
(Lee, S) ⓘ 		Kyungpook Natl Univ, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
페이지 이동: